Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells

Shekhar Srivastava1, Kyung Ko, Papiya Choudhury

  • 1Department of Pharmacology, The Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.

Insights

Myotubularin-related protein 6 (MTMR6) inhibits the KCa3.1 channel, a key player in T-cell activation. This finding reveals MTMR6

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • T-cell activation involves a rapid rise in intracellular calcium (Ca2+) levels, mediated by the T-cell receptor (TCR).
  • Potassium (K+) channels are crucial for maintaining the membrane potential necessary for driving Ca2+ influx into T lymphocytes.

Purpose of the Study:

  • To investigate the role of the Ca2+-activated K+ channel, KCa3.1, in T-cell activation.
  • To elucidate the regulatory mechanism of KCa3.1 by phosphatidylinositol-3 phosphate (PI(3)P) and its associated phosphatases, specifically myotubularin-related protein 6 (MTMR6).

Main Methods:

  • Investigated the interaction between KCa3.1, PI(3)P, and MTMR6 in reactivated naive and central memory T cells.
  • Assessed the impact of MTMR6-mediated inhibition of KCa3.1 on Ca2+ influx and proliferation in human CD4 T cells.

Main Results:

  • The Ca2+-activated K+ channel, KCa3.1, requires PI(3)P for its activation.
  • Myotubularin-related protein 6 (MTMR6) inhibits KCa3.1 channel activity.
  • MTMR6 acts as a negative regulator of Ca2+ influx and proliferation in reactivated human CD4 T cells by inhibiting KCa3.1.

Conclusions:

  • MTMR6 plays a significant role in regulating Ca2+ influx in activated CD4 T cells.
  • MTMR6 is critical in establishing a threshold for T-cell activation, highlighting a novel regulatory pathway involving PI(3)P and MTMR6.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...